FMP
Alimera Sciences, Inc.
ALIM
NASDAQ
Inactive Equity
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
5.54 USD
-0.01 (-0.181%)
Mr. Richard S. Eiswirth Jr.
Healthcare
Drug Manufacturers - Specialty & Generic
NASDAQ
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
0001267602
US0162592028
016259202
6310 Town Square
678 990 5740
US
154
Nov 4, 2019
Mr. Jason Werner
Chief Operating Officer
225.66k
1978
Dr. David Dyer M.D.
Chief Retina Specialist
0
N/A
Dr. Philip Ashman Ph.D.
President of International Operations
516.98k
1965
Christopher S. Visick
Vice President, General Counsel & Secret...
0
N/A
Mr. Todd Michael Wood
President of U.S. Operations
0
1969
Mr. Elliot Maltz CPA
Chief Financial Officer & Treasurer
0
1985
Mr. Richard S. Eiswirth Jr.
Chief Executive Officer & Director
949.27k
1968
Mr. David R. Holland
Co-Founder, Chief Marketing Officer and ...
413.5k
1964
As of December 31, 2024, the total employee count stands at 154, with compensation values reflecting the last fiscal year ending on that date. Pay encompasses salary, bonuses, etc., All figures are in USD.